Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- Aflac Cancer Center and Blood Disorders Service of Children'S Healthcare of Atlanta - Scottish Ritecampus
Atlanta, Georgia, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Floating Hospital for Children
Boston, Massachusetts, United States
- Ccop - Columbia River Oncology Program
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Baylor College of Medicine
Houston, Texas, United States
- Ccop - Scott and White Hospital
Temple, Texas, United States
- Ccop - Marshfield Clinic Research Foundation
Marshfield, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Apr 2001
- Primary completion
- 30 Sept 2005
- Completion
- 31 Jan 2012
- Last update posted
- 13 Feb 2014
- Registered enrollment
- 42
- Registry id
- NCT00017368
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.